Table of Contents
ISRN Pharmaceutics
Volume 2012 (2012), Article ID 369270, 9 pages
http://dx.doi.org/10.5402/2012/369270
Research Article

Efficient Nonviral Gene Therapy Using Folate-Targeted Chitosan-DNA Nanoparticles In Vitro

1Orthopaedics Research Laboratory, Research Center, Sacré-Coeur Hospital, University of Montreal, 5400 West Gouin Boulevard, Montreal, QC, Canada H4J 1C5
2Faculty of Pharmacy and Department of Physical Chemistry and Polymer Science, University of Montreal, Pavillon J.A. Bombardier, C.P. 6128, Succursale Centre-ville, Montreal, QC, H3C 3J7 , Canada
3Orthopaedic Cellular and Molecular Biology Laboratory, Institute of Health Sciences, Chinese Academy of Sciences and Shanghai Jiao Tong University School of Medicine, 225 South Chongqing Road, Shanghai 200025, China

Received 15 November 2011; Accepted 12 December 2011

Academic Editors: F.-R. Chang and J. Lee

Copyright © 2012 Christian Jreyssaty et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Porteous, J. R. Dorin, G. McLachlan et al., “Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis,” Gene Therapy, vol. 4, no. 3, pp. 210–218, 1997. View at Google Scholar · View at Scopus
  2. S. Youjin and Y. Jun, “The treatment of hemophilia A: from protein replacement to AAV-mediated gene therapy,” Biotechnology Letters, vol. 31, no. 3, pp. 321–328, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Liu, I. Santisteban, L. M. Burroughs et al., “Immunologic reconstitution during PEG-ADA therapy in an unusual mosaic ADA deficient patient,” Clinical Immunology, vol. 130, no. 2, pp. 162–174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Braun, “Muscular gene transfer using nonviral vectors,” Current Gene Therapy, vol. 8, no. 5, pp. 391–405, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Ulug, N. Vasavda, R. Kumar et al., “Hydroxyurea therapy lowers circulating DNA levels in sickle cell anemia,” American Journal of Hematology, vol. 83, no. 9, pp. 714–716, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Gao, K. S. Kim, and D. Liu, “Nonviral gene delivery: what we know and what is next,” The American Association of Pharmaceutical Scientists Journal, vol. 9, no. 1, pp. E92–E104, 2007. View at Google Scholar
  7. S. Mansouri, P. Lavigne, K. Corsi, M. Benderdour, E. Beaumont, and J. C. Fernandes, “Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 57, no. 1, pp. 1–8, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Marsh and A. Helenius, “Virus entry: open sesame,” Cell, vol. 124, no. 4, pp. 729–740, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. E. M. Campbell and T. J. Hope, “Gene therapy progress and prospects: viral trafficking during infection,” Gene Therapy, vol. 12, no. 18, pp. 1353–1359, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. T. J. Oligino, Q. Yao, S. C. Ghivizzani, and P. Robbins, “Vector systems for gene transfer to joints,” Clinical Orthopaedics and Related Research, supplement 379, pp. S17–S30, 2000. View at Google Scholar · View at Scopus
  11. T. Niidome and L. Huang, “Gene therapy progress and prospects: nonviral vectors,” Gene Therapy, vol. 9, no. 24, pp. 1647–1652, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Nishikawa and L. Huang, “Nonviral vectors in the new millennium: delivery barriers in gene transfer,” Human Gene Therapy, vol. 12, no. 8, pp. 861–870, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Zhang, C. Yu, XuShi, C. Zhang, T. Tang, and K. Dai, “Direct chitosan-mediated gene delivery to the rabbit knee joints in vitro and in vivo,” Biochemical and Biophysical Research Communications, vol. 341, no. 1, pp. 202–208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Borchard, “Chitosans for gene delivery,” Advanced Drug Delivery Reviews, vol. 52, no. 2, pp. 145–150, 2001. View at Publisher · View at Google Scholar
  15. H. Q. Mao, K. Roy, V. L. Troung-Le et al., “Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency,” Journal of Controlled Release, vol. 70, no. 3, pp. 399–421, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. J. C. Fernandes, M. J. Tiera, and F. M. Winnik, “DNA-chitosan nanoparticles for gene therapy: current knowledge and future trends,” in Biological and Pharmaceutical Nanomaterial, C. S. S. R. Kumar, Ed., pp. 68–99, Wiley-VCH, Weinheim, Germany, 2006. View at Google Scholar
  17. M. J. Turk, G. J. Breur, W. R. Widmer et al., “Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis,” Arthritis and Rheumatism, vol. 46, no. 7, pp. 1947–1955, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Sabharanjak and S. Mayor, “Folate receptor endocytosis and trafficking,” Advanced Drug Delivery Reviews, vol. 56, no. 8, pp. 1099–1109, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Sudimack and R. J. Lee, “Targeted drug delivery via the folate receptor,” Advanced Drug Delivery Reviews, vol. 41, no. 2, pp. 147–162, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Mima, M. Miya, R. Iwamoto, and S. Yoshikawa, “Highly deacetylated chitosan and its properties,” Journal of Applied Polymer Science, vol. 28, no. 6, pp. 1909–1917, 1983. View at Publisher · View at Google Scholar · View at Scopus
  21. K. C. Cho, S. H. Kim, J. H. Jeong, and T. G. Park, “Folate receptor-mediated gene delivery using folate-poly(ethylene glycol)-poly(L-lysine) conjugate,” Macromolecular Bioscience, vol. 5, no. 6, pp. 512–519, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Kiang, J. Wen, H. W. Lim, and K. W. Leong, “The effect of the degree of chitosan deacetylation on the efficiency of gene transfection,” Biomaterials, vol. 25, no. 22, pp. 5293–5301, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. Addgene, Molecular Biology Reference, Genetic Code, 2003–2008, http://www.addgene.org/pgvec1.
  24. K. Corsi, F. Chellat, L. Yahia, and J. C. Fernandes, “Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles,” Biomaterials, vol. 24, no. 7, pp. 1255–1264, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. J. C. Fernandes, H. Wang, C. Jreyssaty et al., “Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis,” Molecular Therapy, vol. 16, no. 7, pp. 1243–1251, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Bozkir and O. M. Saka, “Chitosan-DNA nanoparticles: effect on DNA integrity, bacterial transformation and transfection efficiency,” Journal of Drug Targeting, vol. 12, no. 5, pp. 281–288, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. H. G. Jo, K. H. Min, T. H. Nam, S. J. Na, J. H. Park, and S. Y. Jeong, “Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats,” Archives of Pharmacal Research, vol. 31, no. 7, pp. 918–923, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Lavertu, S. Méthot, N. Tran-Khanh, and M. D. Buschmann, “High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation,” Biomaterials, vol. 27, no. 27, pp. 4815–4824, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Turan and K. Nagata, “Chitosan-DNA nanoparticles: the effect of cell type and hydrolysis of chitosan on in vitro DNA transfection,” Pharmaceutical Development and Technology, vol. 11, no. 4, pp. 503–512, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. J. A. Reddy, L. S. Haneline, E. F. Srour, A. C. Antony, D. W. Clapp, and P. S. Low, “Expression and functional characterization of the β-isoform of the folate receptor on CD34+ cells,” Blood, vol. 93, no. 11, pp. 3940–3948, 1999. View at Google Scholar · View at Scopus
  31. D. Lee, R. Lockey, and S. Mohapatra, “Folate receptor-mediated cancer cell specific gene delivery using folic acid-conjugated oligochitosans,” Journal of Nanoscience and Nanotechnology, vol. 6, no. 9-10, pp. 2860–2866, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Nakashima-Matsushita, T. Homma, S. Yu et al., “Selective expression of folate receptor β and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis,” Arthritis and Rheumatism, vol. 42, no. 8, pp. 1609–1616, 1999. View at Publisher · View at Google Scholar · View at Scopus